Patent Assignment
Reel/Frame 020518/0518
Security Agreement
Recorded: 2008-02-18
Received: 2008-02-18
Pages: 11
Assignor
MEDICAL RESEARCH INSTITUTE
Executed: 2008-02-13
Assignee
WACHOVIA CAPITAL FINANCE CORPORATION (WESTERN)
251 SOUTH LAKE AVENUE, SUITE 900, PASADENA, CA, 91101, UNITED STATES
Covered Properties
(12)
Oral Formulation of Creatine Derivatives and Method of Manufacturing Same
Application:
11/561,821 →
Controlled Release Lipoic Acid
Application:
11/382,414 →
Controlled release arginine alpha-ketoglutarate
Application:
11/240,790 →
Controlled release alpha lipoic acid formulation with an inositol compound
Application:
11/199,919 →
Controlled Release Arginine Alpha-Ketoglutarate
Application:
11/026,430 →
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
Application:
10/947,054 →
Plastic Slab Bolster Upper
Application:
10/726,051 →
Oral formulation of lipid soluble thiamine and lipoic acid
Application:
10/693,837 →
Controlled Release Lipoic Acid
Application:
10/412,559 →
Controlled Release Arginine Alpha Ketoglutarate
Application:
10/226,646 →
Plastic Slab Bolster Upper
Application:
10/223,387 →
Controlled Release Lipoic Acid
Application:
09/755,890 →